A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.
(2005) In Cancer Biotherapy & Radiopharmaceuticals 20(4). p.457-466
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/142626
- author
- Lindén, Ola LU ; Kurkus, Jan LU ; Garkavij, Michael LU ; Cavallin-Ståhl, Eva LU ; Ljungberg, Michael LU ; Nilsson, Rune LU ; Ohlsson, Tomas G LU ; Sandberg, Bengt ; Strand, Sven-Erik LU and Tennvall, Jan LU
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Cancer Biotherapy & Radiopharmaceuticals
- volume
- 20
- issue
- 4
- pages
- 457 - 466
- publisher
- Mary Ann Liebert, Inc.
- external identifiers
-
- pmid:16114994
- wos:000231487500010
- ISSN
- 1557-8852
- language
- English
- LU publication?
- yes
- id
- 6f2ec2dc-efaf-43ee-b086-200ff310f19d (old id 142626)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16114994&dopt=Abstract
- date added to LUP
- 2016-04-01 16:46:13
- date last changed
- 2018-11-21 20:44:04
@article{6f2ec2dc-efaf-43ee-b086-200ff310f19d,
author = {{Lindén, Ola and Kurkus, Jan and Garkavij, Michael and Cavallin-Ståhl, Eva and Ljungberg, Michael and Nilsson, Rune and Ohlsson, Tomas G and Sandberg, Bengt and Strand, Sven-Erik and Tennvall, Jan}},
issn = {{1557-8852}},
language = {{eng}},
number = {{4}},
pages = {{457--466}},
publisher = {{Mary Ann Liebert, Inc.}},
series = {{Cancer Biotherapy & Radiopharmaceuticals}},
title = {{A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.}},
url = {{http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16114994&dopt=Abstract}},
volume = {{20}},
year = {{2005}},
}